High-Dose chemo combo shows promise for tough breast cancers
Disease control
Completed
This study tested a combination of two chemotherapy drugs (epirubicin and docetaxel) at increasing doses, along with a drug to help the immune system recover (pegfilgrastim), in 93 women with locally advanced or inflammatory breast cancer. The goal was to see how well the treatme…
Phase: PHASE1, PHASE2 • Sponsor: NCIC Clinical Trials Group • Aim: Disease control
Last updated May 26, 2026 12:09 UTC